• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸腔积液中血管内皮生长因子、转化生长因子-β、白细胞介素-8 和乳酸脱氢酶与腺苷脱氨酶比值的诊断价值。

Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.

机构信息

Department of Respiratory Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka City, Tokyo, 181-8611, Japan.

Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama-shi, Tokyo, 208-0011, Japan.

出版信息

Lung. 2018 Apr;196(2):249-254. doi: 10.1007/s00408-018-0090-1. Epub 2018 Jan 20.

DOI:10.1007/s00408-018-0090-1
PMID:29353318
Abstract

PURPOSE

We studied the diagnostic value of cytokines, including vascular endothelial growth factor (VEGF), transforming growth factor-β (TGF-β), and interleukin-8 (IL-8), and the ratio of lactate dehydrogenase (LDH) to adenosine deaminase (ADA) in pleural fluid.

METHODS

Prospective analysis of 44 inpatients or outpatients with pleural fluid, from December 2016 to March 2017 was conducted.

RESULTS

We enrolled patients with malignant pleural effusion (MPE, N = 15), empyema (N = 11), parapneumonic effusion (PPE, N = 7), chronic renal failure (CRF)/chronic heart failure (CHF) (N = 7), and tuberculous pleural effusion (TBPE, N = 4). The pleural fluid values of IL-8 and VEGF were significantly higher in empyema patients than in CRF/CHF or PPE patients. In all patients, the pleural fluid VEGF and IL-8 values were significantly positively correlated (r = 0.405, p = 0.006; r = 0.474, p = 0.047, respectively). TGF-β was elevated in patients with empyema, PPE, TBPE, and MPE. The pleural LDH-to-ADA ratio in patients with MPE or empyema/PPE was significantly higher than in patients with CRF/CHF or TBPE. LDH and ADA levels correlated significantly only in patients with MPE (r = 0.648, p = 0.009) and empyema/PPE (r = 0.978, p < 0.001).

CONCLUSIONS

VEGF and IL-8 production in the pleural cavity appear to accelerate the progression of PPE to empyema, by enhancing vascular permeability associated with inflammation. Sequential sampling would be needed to confirm this. The pleural LDH/ADA ratio may be a useful diagnostic tool for discriminating between various pleural effusion etiologies.

摘要

目的

我们研究了细胞因子(包括血管内皮生长因子 [VEGF]、转化生长因子-β [TGF-β]和白细胞介素-8 [IL-8])以及胸腔积液中乳酸脱氢酶(LDH)与腺苷脱氨酶(ADA)比值的诊断价值。

方法

对 2016 年 12 月至 2017 年 3 月期间的 44 名住院或门诊胸腔积液患者进行前瞻性分析。

结果

我们纳入了恶性胸腔积液(MPE,N=15)、脓胸(N=11)、类肺炎性胸腔积液(PPE,N=7)、慢性肾衰竭/慢性心力衰竭(CRF/CHF,N=7)和结核性胸腔积液(TBPE,N=4)患者。脓胸患者胸腔积液中 IL-8 和 VEGF 水平明显高于 CRF/CHF 或 PPE 患者。在所有患者中,胸腔积液 VEGF 和 IL-8 值呈显著正相关(r=0.405,p=0.006;r=0.474,p=0.047)。TGF-β 在脓胸、PPE、TBPE 和 MPE 患者中升高。在 MPE 或脓胸/PPE 患者中,胸腔积液 LDH/ADA 比值明显高于 CRF/CHF 或 TBPE 患者。仅在 MPE(r=0.648,p=0.009)和脓胸/PPE 患者(r=0.978,p<0.001)中,LDH 和 ADA 水平呈显著相关。

结论

胸腔内 VEGF 和 IL-8 的产生似乎通过增强与炎症相关的血管通透性,加速 PPE 向脓胸的进展。需要连续取样来证实这一点。胸腔积液 LDH/ADA 比值可能是鉴别各种胸腔积液病因的有用诊断工具。

相似文献

1
Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.胸腔积液中血管内皮生长因子、转化生长因子-β、白细胞介素-8 和乳酸脱氢酶与腺苷脱氨酶比值的诊断价值。
Lung. 2018 Apr;196(2):249-254. doi: 10.1007/s00408-018-0090-1. Epub 2018 Jan 20.
2
A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels.一种通过使用胸腔乳酸脱氢酶与腺苷脱氨酶比值和癌胚抗原水平来鉴别类肺炎性胸腔积液和脓胸与其他疾病的新型诊断方法。
Medicine (Baltimore). 2019 Mar;98(13):e15003. doi: 10.1097/MD.0000000000015003.
3
The pleural fluid lactate dehydrogenase/adenosine deaminase ratio differentiates between tuberculous and parapneumonic pleural effusions.胸腔积液乳酸脱氢酶/腺苷脱氨酶比值可区分结核性和类肺炎性胸腔积液。
BMC Pulm Med. 2017 Dec 4;17(1):168. doi: 10.1186/s12890-017-0526-z.
4
The role of pleural fluid lactate dehydrogenase-to-adenosine deaminase ratio in differentiating the etiology of pleural effusions.胸腔积液乳酸脱氢酶-腺苷脱氨酶比值在鉴别胸腔积液病因中的作用。
Chin J Physiol. 2022 May-Jun;65(3):105-108. doi: 10.4103/cjp.cjp_104_21.
5
Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.胸腔积液乳酸脱氢酶/腺苷脱氨酶比值对结核性胸腔积液诊断的临床意义。
BMC Pulm Med. 2024 May 15;24(1):241. doi: 10.1186/s12890-024-03055-0.
6
Adenosine deaminase-based measurement in the differential diagnosis of pleural effusion: a multicenter retrospective study.基于腺苷脱氨酶的胸腔积液鉴别诊断测量:一项多中心回顾性研究。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231155747. doi: 10.1177/17534666231155747.
7
Differentiating between tuberculous and non-tuberculous pleural effusions using the pleural fluid ratio of 10× adenosine deaminase/lactate dehydrogenase.利用胸腔积液中10倍腺苷脱氨酶与乳酸脱氢酶的比值鉴别结核性和非结核性胸腔积液。
J Thorac Dis. 2023 May 30;15(5):2627-2635. doi: 10.21037/jtd-23-383. Epub 2023 May 29.
8
Cancer ratio and other new parameters for differentiation between malignant and nonmalignant pleural effusions.癌症比例和其他用于区分恶性和非恶性胸腔积液的新参数。
Pol Arch Intern Med. 2018 Jun 30;128(6):354-361. doi: 10.20452/pamw.4278. Epub 2018 Jun 5.
9
Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion.结核性胸腔积液中的肿瘤坏死因子、白细胞介素-1和腺苷脱氨酶
Respir Med. 1996 Feb;90(2):95-8. doi: 10.1016/s0954-6111(96)90205-x.
10
Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.用于鉴别以中性粒细胞为主且腺苷脱氨酶水平高的结核性和类肺炎性胸腔积液的胸腔积液腺苷脱氨酶/血清C反应蛋白比值
Infection. 2017 Feb;45(1):59-65. doi: 10.1007/s15010-016-0928-5. Epub 2016 Aug 3.

引用本文的文献

1
High levels of the pleural fluid macrophage ratio and mesothelial cell ratio associated with malignant pleural effusion diagnosis: Observational study.高水平的胸腔积液巨噬细胞比率和间皮细胞比率与恶性胸腔积液诊断相关:观察性研究。
Medicine (Baltimore). 2025 Aug 8;104(32):e43775. doi: 10.1097/MD.0000000000043775.
2
Interleukin-8/CXCR1 Signaling Contributes to the Progression of Pulmonary Adenocarcinoma Resulting in Malignant Pleural Effusion.白细胞介素-8/CXCR1 信号通路促进肺腺癌进展导致恶性胸腔积液。
Cells. 2024 Jun 3;13(11):968. doi: 10.3390/cells13110968.
3
Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.

本文引用的文献

1
A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.一种利用胸腔CT上的胸膜分裂征和胸腔积液量来鉴别复杂性类肺炎性胸腔积液/脓胸与类肺炎性胸腔积液的简单方法。
PLoS One. 2015 Jun 15;10(6):e0130141. doi: 10.1371/journal.pone.0130141. eCollection 2015.
2
The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.血管内皮生长因子在恶性胸腔积液发病机制、诊断和治疗中的作用。
Curr Oncol Rep. 2013 Jun;15(3):207-16. doi: 10.1007/s11912-013-0315-7.
3
胸腔积液乳酸脱氢酶/腺苷脱氨酶比值对结核性胸腔积液诊断的临床意义。
BMC Pulm Med. 2024 May 15;24(1):241. doi: 10.1186/s12890-024-03055-0.
4
Targeting the PAI-1 Mechanism with a Small Peptide Increases the Efficacy of Alteplase in a Rabbit Model of Chronic Empyema.用一种小肽靶向纤溶酶原激活物抑制剂-1机制可提高阿替普酶在兔慢性脓胸模型中的疗效。
Pharmaceutics. 2023 May 14;15(5):1498. doi: 10.3390/pharmaceutics15051498.
5
Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations.基于癌症类型、组织学类型和表皮生长因子受体突变,恶性胸腔积液患者胸腔液中淀粉酶水平的差异。
Intern Med. 2023 Dec 15;62(24):3601-3607. doi: 10.2169/internalmedicine.1804-23. Epub 2023 Apr 21.
6
Characteristics of pleural effusion with a high adenosine deaminase level: a case-control study.胸腔积液腺苷脱氨酶水平升高的特征:病例对照研究。
BMC Pulm Med. 2022 Sep 21;22(1):359. doi: 10.1186/s12890-022-02150-4.
7
Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.结核中的血管内皮生长因子水平:系统评价和荟萃分析。
PLoS One. 2022 May 25;17(5):e0268543. doi: 10.1371/journal.pone.0268543. eCollection 2022.
8
Diagnostic method for malignant pleural effusion distinguishing malignant mesothelioma from lung cancer using pleural carcinoembryonic antigen and hyaluronic acid levels.采用胸腔癌胚抗原和透明质酸水平对恶性胸腔积液进行良、恶性胸膜间皮瘤与肺癌鉴别诊断的方法。
Medicine (Baltimore). 2022 Jan 7;101(1):e28517. doi: 10.1097/MD.0000000000028517.
9
Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?恶性胸腔积液——洞察局部抗肿瘤T细胞免疫的窗口?
Front Oncol. 2021 Apr 27;11:672747. doi: 10.3389/fonc.2021.672747. eCollection 2021.
10
Acellular fraction from malignant effusions has cytotoxicity in breast cancer cells.恶性胸腔积液的无细胞成分对乳腺癌细胞具有细胞毒性。
Mol Clin Oncol. 2021 May;14(5):106. doi: 10.3892/mco.2021.2268. Epub 2021 Mar 20.
Pleural fluid analysis: standstill or a work in progress?
胸腔积液分析:停滞不前还是仍在发展?
Pulm Med. 2012;2012:716235. doi: 10.1155/2012/716235. Epub 2012 Feb 1.
4
Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.胸腔积液中血管内皮生长因子用于鉴别良恶性来源及其临床应用
Interact Cardiovasc Thorac Surg. 2011 Mar;12(3):420-4. doi: 10.1510/icvts.2010.250357. Epub 2010 Dec 20.
5
Immunological mechanisms in pleural disease.胸膜疾病中的免疫机制。
Eur Respir J. 2003 Mar;21(3):539-44. doi: 10.1183/09031936.03.00403902.
6
Clinical practice. Pleural effusion.临床实践。胸腔积液。
N Engl J Med. 2002 Jun 20;346(25):1971-7. doi: 10.1056/NEJMcp010731.
7
Vascular endothelial growth factor level correlates with transforming growth factor-beta isoform levels in pleural effusions.血管内皮生长因子水平与胸腔积液中转化生长因子-β亚型水平相关。
Chest. 2000 Dec;118(6):1747-53. doi: 10.1378/chest.118.6.1747.
8
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline.肺炎旁胸腔积液的内科与外科治疗:循证指南
Chest. 2000 Oct;118(4):1158-71. doi: 10.1378/chest.118.4.1158.